Aminopyrine-induced blood dyscrasias - still a problem in many parts of the world

Pharmacoepidemiology and Drug Safety

Volumn 5, Issue 4, 1996, Pages 215-219

  Chan, Thomas Y K ^a   Chan, Anthony W K ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

Adverse drug reactions; Agranulocytosis; Aminopyrine; Aplastic anaemia; Blood dyscrasias; Pyrazolones

Indexed keywords

AMINOPHENAZONE;

AGRANULOCYTOSIS; APLASTIC ANEMIA; BLOOD DYSCRASIA; HUMAN; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0029810801     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199607)5:4<215::AID-PDS208>3.0.CO;2-5     Document Type: Review

References (42)

1. Insel, P. A. Analgesic-antipyretics and antiinflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 8th edn, Vol. 1. Goodman Gilman, A., Rall, T. W., Nies, A. S. and Taylor, P. (Eds), McGraw-Hill, New York, 1991, pp. 638-681.
2. British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary. No. 28, 1994.
3. Kracke, R. R. and Parker, F. P. The etiology of granulopenia (agranulocytosis). Journal of Laboratory and Clinical Medicine 1934; 119: 799-818.
4. Heit, W. F. W. Hematologic effects of antipyretic analgesics. Drug-induced agranulocytosis. American Journal of Medicine 1983; 75(5A): 65-69.
5. Association of Clinical Pathologists. Lancet 1951; i: 389.
6. Huguley, C. M. Drug induced blood dyscrasias II. Agranulocytosis. Journal of the American Medical Association 1964; 188: 817-818.
7. Discombe, G. Agranulocytosis caused by amidopyrine (aminopyrine): avoidable cause of death. British Medical Journal 1952; i: 1270-1271.
8. Gordon-Smith, E. C. Drug-induced cytopenias. In: Haematological Aspects of Systemic Disease. Delamore, I. W. and Liu Yin, J. A. (Eds), Bailliere Tindall, London, 1990, pp. 329-376.
9. Bottiger, L. E. and Westerholm, B. Drug-induced blood dyscrasias in Sweden. British Medical Journal 1973; 3: 339-343.
10. Anonymous. Risks of agranulocytosis and aplastic anaemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anaemia Study. Journal of the American Medical Association 1986; 256: 1749-1757.
11. Huguley, C. H. Agranulocytosis induced by dipyrone, a hazardous antipyretic and analgesic. Journal of the American Medical Association 1964; 189: 938-941.
12. Zernechel, C. F. Aminopyrine and agranulocytosis. Review and report of six cases. North Carolina Medical Journal 1967; 28: 91-98.
13. Hauswaldt, C, Hunstein, W. and Perings, E. Amidopyrine agranulocytosis accompanied by erythroblast depression. A case report with skin-test results. German Medical Monthly 1967; 12: 265-268.
14. Heath, D. Necrosis of the rectum complicating agranulocytosis due to amidopyrine. Proceedings of the Royal Society of Medicine 1968; 61: 502-503.
15. Palva, I. P. and Mustala, O. O. Drug-induced agranulocytosis, with special reference to aminophenazone. I. Adults. Acta Medica Scandinavica 1970; 187: 109-115.
16. Kantero, I., Mustala, O. O. and Palva, I. P. Drug-induced agranulocytosis, with special reference to aminophenazone. IV. Children. Acta Medica Scandinavica 1972; 192: 327-330.
17. Evers, K. G. and Knoop, U. F. Miconazole treatment of Candida sepsis in aminophenazone induced agranulocytosis. Acta Paediatrica Belgica 1978; 31: 151-153.
18. Arneborn, P. and Pamblad, J. Drug-induced neutropenia - a survey for Stockholm, 1973-1978. Acta Medica Scandinavica 1982; 212: 289-292.
19. Schmidt, P. M. and Clement, F. [A propos of 7 cases of aminopyrine agranulocytosis]. [French]. Schweizerische Medizinische Wochenschrift. Journal Suisse de Medecine 1968; 98: 1678-1680.
20. Goudemand, J., Plouvier, J. Bauters, F. and Goudemand, M. [Acute agranulocytosis induced by pyramidon or phenothiazines. A propos of 31 cases]. [French]. Semaine des Hopitaux 1976; 52: 1513-1520.
21. Hennemann, H. H. [Amidopyrine agranulocytosis]. [German]. Nippon Saikingaku Zasshi. Japanese Journal of Bacteriology 1970; 25: 220.
22. Scholz, H. and Meyer, W. [Aminophenazone induced agranulocytosis and intrahepatic cholestasis in a 12-year-old girl]. [German]. Deutsche Gesundheitswesen 1972; 27: 205-209.
23. Hennemann, H. H. and Schief, A. [Recurrences of agranulocytosis (author's transl.)]. [German]. Deutsche Medizinische Wochenschrift 1975; 100: 519-520, 525-526.
24. Von Feiten, A., Muller-Schoop, J. and Gmur, J. [Non-HL-A specific autoantibody against granulocytes, lymphocytes and thrombocytes in a patient with agranulocytosis due to pyrazolone]. [German]. Schweizerische Medizinische Wochenschrift. Journal Suisse de Medecine 1975; 105: 1598.
25. Jelic, O. [Agranulocytosis caused by aminopyrine]. [SerboCroatian (Roman)] Lijecnicki Vjesnik 1969; 91: 427-430.
26. Boersma, J. W. [Prevention of agranulocytosis during treatment with pyrazolone derivatives, especially with aminophenazone (Pyramidon)]. [Dutch]. Nederlands Tijdschrift voor Geneeskunde 1973; 117: 376-383.
27. Milman, N. and Isager, H. [Agranulocytosis following ingestion of a foreign over-the-counter drug containing aminophenazone (Optalidon)]. [Danish]. Ugeskrift for Laeger 1978; 140: 1168-1169.
28. Cazzola, M., Cherie Ligniere, E. L. and Perugini, S. [Chronic granulocytopenia associated with exposure to isopropylphenazone, complicated by two episodes of acute agranulocytosis caused by aminopyrine (author's transl.)]. [Italian]. Haematologica 1978; 63: 67-73.
29. Anonymous. Toxic etiology of aplastic anaemia. The Cooperative Study Group for Aplastic and Refractory Anemias. Sexually Transmitted Diseases 1984; 11: (4 Suppl.): 343-346.
30. Lau, Y. N., Woo, E., Lai, C. L. and Hui, W. M. Aplastic anaemia induced by aminopyrine - a hazardous antipyretic and analgesic. Journal of the Hong Kong Medical Association 1988; 40: 293-294.
31. Anonymous. Risk factors analysis of leukemia and aplastic anaemia in China. Chinese Epidemiologic Study Group of Leukemia and Aplastic anemia. [Chinese]. Chung-Kuo i Hsueh Ko Hsuen Yuen Hsueh Pao Acta Academiae Medicinae Sinicae 1992; 14: 185-189.
32. Yang, C. and Zhang X. Incidence survey of aplastic anemia in China. Chinese Medical Sciences Journal 1991; 6: 203-207.
33. Kiatboonsri, P. and Richter, J. Unethical trials of dipyrone in Thailand [letter]. Lancet 1988; ii: 1491.
34. Kiatboonsri, P. and Richter, J. Dipyrone trials in Thailand [letter]. Lancet 1989; ii: 107.
35. Pinto Pereira, L. M. A fixed drug eruption to Naralgin (dipyrone) tablets. West Indian Medical Journal 1994; 43: 146-147.
36. Epstein, P. and Yudkin, J. S. Agranulocytosis in Mozambique due to aminopyrine, a drug withdrawn in the west [letter]. Lancet 1980; ii: 254-255.
37. Hargis, J. B., La Russa, V. F., Redmond, J., Kessler, S. W. and Wright, D. G. Agranulocytosis associated with 'Mexican aspirin' (dipyrone): evidence for an autoimmune mechanism affecting multipotential haematopoietic progenitors. American Journal of Hematology 1989; 31: 213-215.
38. Epidemiology Committee, Hong Kong College of General Practitioners. The aminopyrines: opinions and experience among general practitioners in Hong Kong. Hong Kong Practitioners 1983; 5: 765-772.
39. Bottiger, L. E. Epidemiology and aetiology of aplastic anaemia Hamatologie und Bluttransfusion 1979; 24: 27-37.
40. Gordon-Smith, E. C. and Issaragrisil, S. Epidemiology of aplastic anaemia. Bailliere's Clinical Haematology 1992; 5: 475-491.
41. Ries, C. A. and Sahud, M. A. Agranulocytosis caused by Chinese herbal medicines. Dangers of medications containing aminopyrine and phenylbutazone. Journal of the American Medical Association 1975; 231: 352-355.
42. Chan, T. Y. K., Chan, J. C. N., Tomlinson, B. and Critchley, J. A. J. H. Chinese herbal medicines revisited: a Hong Kong perspective. Lancet 1993; 342: 1532-1534.